Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Yimeng WangKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Zhibin WangKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Yanping SunKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.ORCID 0000-0003-0105-5137
Mingtao ZhuKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Yong JiangKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Haodong BaiKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Bingyou YangKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Haixue KuangKey Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Funding
Chief Scientist of Qi-Huang Project of National Traditional Chinese Medicine Inher-itance and Innovation "One Hundred Million" Talent Project (Grant Number: [2021] No. 7), Grant Number: [2021] No. 7Heilongjiang Touyan Innovation Team Program (Grant Number: [2019] No. 5). Grant Number: [2019] No. 5National Famous Old Traditional Chinese Medicine Experts Inheritance Studio Con-struction Program of National Administration of TCM (Grant Number: [2022] No. 75), Grant Number: [2022] No. 75Qi-Huang Scholar of National Traditional Chinese Medicine Leading Talents Support Program Grant Number: [2018] No. 284Qi-Huang Scholar of National Traditional Chinese Medicine Leading Talents Support Program (Grant Number: [2018] No. 284), Grant Number: [2018] No. 284The Seventh Batch of National Famous Old Traditional Chinese Medicine Experts Ex-perience Heritage Construction Program of National Administration of TCM, (Grant Number: [2022] No. 76), Grant Number: [2022] No. 76
6 · The paper itself
Abstract
Cancer represents one of the most significant health challenges currently facing humanity, and plant-derived antitumour drugs represent a prominent class of anticancer medications in clinical practice. Isovaleryl sucrose esters, which are natural constituents, have been identified as having potential antitumour effects. However, the mechanism of action remains unclear. In this study, 12 isovaleryl sucrose ester components, including five new (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Isovaleryl Sucrose Esters from · full record | OpenQuestion